Notable Players

A Deeper Look At This State

Regulatory Framework

The Michigan Regulatory Agency("MRA") opened up the medical caregiver program in 2008, resulting in mature supply chains within the Michigan cannabis industry. When adult-use legislation was passed in 2019, the MRA allowed medical caregivers to supply adult-use retail and manufacturing operators. This allowed the Michigan adult-use cannabis market to have immediate supply until the MRA cut-off medical caregivers' ability to supply the adult-use operators in September 2020 as the adult-use market matured.

Michigan is an unlimited license market; however, the MRA has given the power to local municipalities to opt-in or out to the state's cannabis regulatory framework, of which nearly 80% have opted out.

Detroit’s delayed entry to the adult-use market has been in limbo for the past two years as a result of a series of lawsuits over issuing licenses.

Notable Market Activity

February 2022 | Red White and Bloom completes acquisition of PharmaCo in an all-stock transaction

September 2021 | Skymint acquires 3Fifteen to become the largest Michigan SSO

September 2021 | TerrAscend announces to acquire GAGE for $545MM

September 2020 | Red White and Bloom acquires Platinum Vape

What's the Play?

Wholesale prices for biomass plummeted in late 2021, resulting in a plethora of new and inexpensive carts, infused products, and cheap flower flooding the market. Marginal market participants need to seek acquirers as their businesses are not sustainable over the long term. Larger, stronger market participants need to consolidate to take cultivation capacity out of the market and stabilize pricing. In short, all players in Michigan better be making moves this upcoming year.

Ranked #3 in the U.S., Michigan is a $2.2B market. Despite the large market size, Michigan has generated little interest from the major MSO's. They have seen fit to deploy scarce capital resources in states with much more restrictive licensing regimes. The previously mentioned market turmoil in late 2021 ensures a continuation of the MSO's "wait and see" approach and will constrain capital flows into the Michigan market. In other words, in-state operators are effectively on their own for the foreseeable future.

Market Snapshot

This Data Point

58,380

This Data Point

58,380

This Data Point

58,380

This Data Point

58,380

This Data Point

58,380

This Data Point

58,380

This Data Point

58,380

This Data Point

594/273

By The Numbers

Population

~10MM

21+ Population

~6.91MM

Annual Tourists

~
125
MM

Medicinal Legalization

2008

Adult-Use Legalization

2019

First Adult-Use Sales

2019

MMJ Patients

~250K

Monthly Revenue

~$200MM

Cultivation Cap

2000 Plants

Cultivation Licenses

537/No Limit (Operational/Limit)

Retail Licenses

518/ No Limit (Operational/Limit)

Retail License Cap per Operator

No Limit

Vertical Integration

Allowed

Delivery

Allowed

MMJ Qualifications

Less Restrictive

Adult Population/ # Retail Licenses

~13.8K

Accepts Out of State MMJ

No

MMJ Patients / # Retail Licenses

Top Cultivators

Notable Market Activity

Quick sentance is needed or wanted

Quick sentance is needed or wanted

Quick sentance is needed or wanted

Proprietary Sharp Capital Advisors data - compiled using various sources including state and local government data

Have questions? Reach out to the team

Co-Founder & CEO
Chicago
Managing Director
Los Angeles
Head of Debt Capital Markets
Chicago
Shit We Don't Know

Have a tip about this state? Let us know!